JP2001519776A5 - - Google Patents

Download PDF

Info

Publication number
JP2001519776A5
JP2001519776A5 JP1998536228A JP53622898A JP2001519776A5 JP 2001519776 A5 JP2001519776 A5 JP 2001519776A5 JP 1998536228 A JP1998536228 A JP 1998536228A JP 53622898 A JP53622898 A JP 53622898A JP 2001519776 A5 JP2001519776 A5 JP 2001519776A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998536228A
Other languages
English (en)
Japanese (ja)
Other versions
JP4290767B2 (ja
JP2001519776A (ja
Filing date
Publication date
Priority claimed from IT97MI000362A external-priority patent/IT1289938B1/it
Application filed filed Critical
Publication of JP2001519776A publication Critical patent/JP2001519776A/ja
Publication of JP2001519776A5 publication Critical patent/JP2001519776A5/ja
Application granted granted Critical
Publication of JP4290767B2 publication Critical patent/JP4290767B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53622898A 1997-02-20 1998-02-12 非水溶性活性成分封入の凍結乾燥リポソームを含む医薬製剤およびその製造方法 Expired - Fee Related JP4290767B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97A000362 1997-02-20
IT97MI000362A IT1289938B1 (it) 1997-02-20 1997-02-20 Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e
PCT/EP1998/000817 WO1998036736A1 (en) 1997-02-20 1998-02-12 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation

Publications (3)

Publication Number Publication Date
JP2001519776A JP2001519776A (ja) 2001-10-23
JP2001519776A5 true JP2001519776A5 (enExample) 2005-10-06
JP4290767B2 JP4290767B2 (ja) 2009-07-08

Family

ID=11376097

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53622898A Expired - Fee Related JP4290767B2 (ja) 1997-02-20 1998-02-12 非水溶性活性成分封入の凍結乾燥リポソームを含む医薬製剤およびその製造方法

Country Status (25)

Country Link
US (1) US6319517B1 (enExample)
EP (1) EP0981332B1 (enExample)
JP (1) JP4290767B2 (enExample)
KR (1) KR100496802B1 (enExample)
CN (1) CN1089581C (enExample)
AR (1) AR011681A1 (enExample)
AT (1) ATE285754T1 (enExample)
AU (1) AU744115B2 (enExample)
BG (1) BG64580B1 (enExample)
CA (1) CA2288958C (enExample)
CZ (1) CZ295998B6 (enExample)
DE (1) DE69828394T2 (enExample)
EA (1) EA001637B1 (enExample)
ES (1) ES2235320T3 (enExample)
GE (1) GEP20022734B (enExample)
HU (1) HU225593B1 (enExample)
IL (1) IL131327A (enExample)
IT (1) IT1289938B1 (enExample)
PL (1) PL190628B1 (enExample)
PT (1) PT981332E (enExample)
SK (1) SK282931B6 (enExample)
TR (1) TR199902025T2 (enExample)
UA (1) UA70296A (enExample)
WO (1) WO1998036736A1 (enExample)
ZA (1) ZA981352B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU762944B2 (en) 1999-06-23 2003-07-10 Cornell Research Foundation Inc. Dehydration/rehydration of marked liposomes on a test device
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
EP1610778A4 (en) * 2003-01-17 2006-05-31 Threshold Pharmaceuticals Inc TREATMENT OF BENIGNER PROSTATE HYPERPLASIA
MX2007012762A (es) 2005-04-12 2008-01-14 Elan Pharma Int Ltd Composiciones de material nanoparticulado y de liberacion controlada que comprende ciclosporina.
WO2008036979A2 (en) * 2006-09-22 2008-03-27 Guilford F Timothy Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes
CN101049504B (zh) * 2007-04-05 2010-05-19 广州立恩生物科技有限公司 一种脂质体药物载体及其制备方法
US9446147B2 (en) 2011-02-24 2016-09-20 The Ohio State University Membrane stabilizing compositions and methods
CA2852777C (en) 2011-10-21 2020-10-27 Celator Pharmaceuticals Inc. Lyophilized liposomes
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
WO2014035206A2 (ko) * 2012-08-31 2014-03-06 중앙대학교 산학협력단 색전용 마이크로스피어의 제조방법 및 약물 함유 나노수송체가 결합된 마이크로스피어의 제조방법
US10722465B1 (en) 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
US11344497B1 (en) 2017-12-08 2022-05-31 Quicksilver Scientific, Inc. Mitochondrial performance enhancement nanoemulsion
KR102649069B1 (ko) 2018-05-31 2024-03-19 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물
EP3813862A1 (en) * 2018-06-27 2021-05-05 Breath Therapeutics GmbH Inhalable compositions comprising macrocyclic immunosuppressants
EA202092893A1 (ru) 2018-06-27 2021-04-19 Брес Терапьютикс Гмбх Фармацевтические композиции в лиофилизированной форме
WO2020027466A1 (ko) * 2018-07-28 2020-02-06 주식회사 엑소코바이오 엑소좀의 동결건조 방법
KR102163806B1 (ko) 2018-07-30 2020-10-07 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물
EA202092892A1 (ru) 2018-12-04 2021-05-27 Брес Терапьютикс Гмбх Ингаляционные композиции, содержащие макроциклические иммуносупрессанты
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
EP3990433A4 (en) 2019-06-25 2023-07-26 Translatum Medicus Inc. METHODS FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
CN111358955B (zh) * 2020-04-01 2023-05-02 重庆理工大学 一种用于治疗脂质代谢疾病的炎症靶向的宾达利纳米粒、制备方法及其应用
JP7508359B2 (ja) * 2020-12-11 2024-07-01 株式会社東芝 脂質粒子の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
FR2542749B1 (fr) * 1983-03-18 1985-07-12 Beghin Say Sa Copolymere allyloligosaccharide-acrylique salifie, procede de preparation du copolymere et application comme super-absorbant
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
US4963362A (en) * 1987-08-07 1990-10-16 Regents Of The University Of Minnesota Freeze-dried liposome mixture containing cyclosporin
US5683714A (en) * 1991-04-19 1997-11-04 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin pharmaceutical formulation
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
AU683957B2 (en) * 1993-11-05 1997-11-27 Amgen, Inc. Liposome preparation and material encapsulation method

Similar Documents

Publication Publication Date Title
JP2000509637A5 (enExample)
JP2000507042A5 (enExample)
JP2000509635A5 (enExample)
JP2002510317A5 (enExample)
JP2001512583A5 (enExample)
JP2001511237A5 (enExample)
JP2000509587A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2001525044A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2000508022A5 (enExample)
JP2001510406A5 (enExample)
JP2000508841A5 (enExample)
JP2001509197A5 (enExample)
JP2000508680A5 (enExample)
JP2000513667A5 (enExample)
JP2001512456A5 (enExample)
JP2002511948A5 (enExample)
JP2001527597A5 (enExample)
JP2000510969A5 (enExample)
JP2000508836A5 (enExample)
JP2000508102A5 (enExample)
JP2001519776A5 (enExample)